Metabolomics

Dataset Information

0

Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma (Liver) - part II

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Liver

DISEASE(S): Chronic Liver Disease,Cancer

PROVIDER: ST001641 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma.
| S-EPMC7795670 | biostudies-literature
Metabolomics Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma (Blood) - part I
| ST001640 | MetabolomicsWorkbench
Unknown CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis.
| S-EPMC12858952 | biostudies-literature
Unknown Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
| S-EPMC3514167 | biostudies-literature
Unknown LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma.
| S-EPMC7216144 | biostudies-literature
Unknown Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma.
| S-EPMC3449193 | biostudies-literature
Unknown Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management.
| S-EPMC11523965 | biostudies-literature
Unknown Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.
| S-EPMC8774293 | biostudies-literature
Unknown Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma.
| S-EPMC8157577 | biostudies-literature
Unknown Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality.
| S-EPMC10139765 | biostudies-literature